Colleen M. Britain

844 citations
7 papers · 609 indexed · h-index 7
Topics
Glycosylation and Glycoproteins Research (5 papers)Galectins and Cancer Biology (5 papers)Peptidase Inhibition and Analysis (2 papers)
Partner nations
United StatesGermany

In The Last Decade

Colleen M. Britain

7 papers receiving 601 citations

Peers

Colleen M. Britain
Comparison fields: 5 of 71
  • Molecular Biology 546
  • Immunology 207
  • Cancer Research 199
  • Oncology 69
  • Cell Biology 56
Replace Mariko Kambe with:
Mariko Kambe Japan
Keli Ma China
Debbie Hall United Kingdom
Vincent Klump United States
Juan Manuel Iglesias Spain
Hiroshi Umeno Japan
Miha Pavšič Slovenia
Esther D. Kers‐Rebel Netherlands
Donna Kersey United States
Kevin O’Hayer United States
Colleen M. Britain relative to Mariko Kambe Japan Mariko Kambe's profile →
Citations per field
00.5×5.8×
Mariko Kambe · 1×
Citations per year

Countries citing papers authored by Colleen M. Britain

Since Specialization
Citations

This map shows the geographic impact of Colleen M. Britain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen M. Britain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen M. Britain more than expected).

Fields of papers citing papers by Colleen M. Britain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen M. Britain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen M. Britain. The network helps show where Colleen M. Britain may publish in the future.

Co-authorship network of co-authors of Colleen M. Britain

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen M. Britain. A scholar is included among the top collaborators of Colleen M. Britain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen M. Britain. Colleen M. Britain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 8
2 41
3 290
4 50
5 99
6 37
7 84

About Colleen M. Britain

Colleen M. Britain is a scholar working on Immunology, Oncology and Molecular Biology, having authored 7 papers that have together received 609 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (5 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (199 citations), Immunology (207 citations) and Molecular Biology (546 citations). Colleen M. Britain has collaborated with scholars based in United States and Germany. Frequent co-authors include Susan L. Bellis, Andrew T. Holdbrooks, Kaitlyn A. Dorsett, Christopher D. Willey, Joshua C. Anderson, Jie Ping, Wei Li, Qin Zhang, Yuping Yang and Jeffrey L. Franklin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026